The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04847466
Brief Title: Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer

First Submitted : April 15, 2021
First Submitted that Met QC Criteria : April 15, 2021
First Posted : April 19, 2021

Last Update Submitted that Met QC Criteria : April 13, 2024
Last Update Posted : April 16, 2024